125
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

An Update on the Epidemiology of Uveitis in an Urban Setting in Northern Madrid, Spain

, MD, , MD, PhD, , MD, PhD & , MD, PhD, FEBOORCID Icon
Pages 1623-1628 | Received 09 Nov 2021, Accepted 08 Jun 2022, Published online: 06 Jul 2022

References

  • Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–1162. doi:10.1136/bjo.2003.037226.
  • Zhang Y, Amin S, Lung KI, Seabury S, Rao N, Toy BC. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: a claims-based analysis. PloS One. 2020;15(8):e0237995. doi:10.1371/journal.pone.0237995.
  • Shirahama S, Kaburaki T, Nakahara H, et al. Epidemiology of uveitis (2013-2015) and changes in the patterns of uveitis (2004-2015) in the central Tokyo area: a retrospective study. BMC Ophthalmol. 2018;18(1):189. doi:10.1186/s12886-018-0871-6.
  • Hart CT, Zhu EY, Crock C, Rogers SL, Lim LL. Epidemiology of uveitis in urban Australia. Clin Exp Ophthalmol. 2019;47(6):733–740. doi:10.1111/ceo.13517.
  • Gray CF, Quill S, Compton M, McAvoy CE, Williams MA. Epidemiology of adult uveitis in a Northern Ireland Tertiary Referral Centre. Ulster Med J. 2019;88:170–173.
  • González-López J, García-Aparicio ÁM, Sánchez-Ponce D, et al. Development and validation of a Bayesian network for the differential diagnosis of anterior uveitis. Eye. 2016;30(6):865–872. doi:10.1038/eye.2016.64.
  • Gómez-Mariscal M, De Arriba F, Revenga M, González-López J. Do season and environment have a role in the incidence of anterior uveitis attacks? Ocul Immunol Inflamm. 2020;28(5):786–790. doi:10.1080/09273948.2019.1636092.
  • García-Aparicio ÁM, Alonso Martín L, Quirós Zamorano R. Prevalence of uveitis in a Spanish population, UveCAM study. Med Clín Engl Ed. 2020;155(11):506–507. doi:10.1016/j.medcle.2019.05.041.
  • Llorenç V, Mesquida M, Sainz de la Maza M, et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol (Copenh). 2015;93(6):561–567. doi:10.1111/aos.12675.
  • Baarsma GS. The epidemiology and genetics of endogenous uveitis: a review. Curr Eye Res. 1992;11(Suppl);1–9. doi:10.3109/02713689208999505.
  • Nakahara H, Kaburaki T, Takamoto M, et al. Statistical analyses of endogenous uveitis patients (2007-2009) in central Tokyo area and comparison with previous studies (1963-2006). Ocul Immunol Inflamm. 2015;23(4):291–296. doi:10.3109/09273948.2014.920036.
  • Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008;146(6):883–889.e1. doi:10.1016/j.ajo.2008.09.001.
  • Servicio Madrileño de Salud. Memoria 2019. 11/2020 ed. http://www.madrid.org/bvirtual/BVCM050222.pdf .Accessed 8 November 2021
  • Testi I, Agrawal R, Mahajan S, et al. Tubercular uveitis: nuggets from collaborative ocular tuberculosis study (COTS)-1. Ocul Immunol Inflamm. 2019:1–9. Published online. doi:10.1080/09273948.2019.1646774.
  • Sun Y, Ji Y. A literature review on Fuchs uveitis syndrome: an update. Surv Ophthalmol. 2020;65(2):133–143. doi:10.1016/j.survophthal.2019.10.003.
  • Megaw R, Agarwal PK. Posner-Schlossman syndrome. Surv Ophthalmol. 2017;62(3):277–285. doi:10.1016/j.survophthal.2016.12.005.
  • Rudwaleit M, van der Heijde D, Landewé R, et al. The assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70(1):25–31. doi:10.1136/ard.2010.133645.
  • Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of rheumatology classification criteria for Systemic lupus erythematosus. Arthritis Rheumatol (Hoboken NJ). 2019;71(9):1400–1412. doi:10.1002/art.40930.
  • International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol JEADV. 2014;28(3):338–347. doi:10.1111/jdv.12107.
  • Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583–1594. doi:10.1136/annrheumdis-2016-209133.
  • Mochizuki M, Smith JR, Takase H, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422. doi:10.1136/bjophthalmol-2018-313356.
  • Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. doi:10.1002/ana.22366.
  • Martini A, Ravelli A, Avcin T, et al. Toward new classification criteria for Juvenile idiopathic arthritis: first steps, pediatric rheumatology international trials organization international consensus. J Rheumatol. 2019;46(2):190–197. doi:10.3899/jrheum.180168.
  • Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–941. doi:10.1136/ard.2005.046300.
  • Mandeville JT, Levinson RD, Holland GN. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol. 2001;46(3):195–208. doi:10.1016/s0039-6257(01)00261-2.
  • Yang P, Zhong Y, Du L, et al. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 2018;136(9):1025–1031. doi:10.1001/jamaophthalmol.2018.2664.
  • Levinson RD, Brezin A, Rothova A, Accorinti M, Holland GN. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol. 2006;141(1):185–187. doi:10.1016/j.ajo.2005.08.025.
  • Efron B, Tibshirani R. An Introduction to the Bootstrap. New York: Chapman & Hall ; 1993. doi:10.1201/9780429246593
  • Fernández-Blázquez MA, Del Ser T, Frades-Payo B, et al. Madrid+90 study on factors associated with longevity: study design and preliminary data. Silva JP, ed. PLOS ONE. 2021;16(5):e0251796. doi:10.1371/journal.pone.0251796.
  • Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713.
  • Lowder C. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. 2011;129(5):545. doi:10.1001/archophthalmol.2010.339.
  • Kempen JH, Altaweel MM, Holbrook JT, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118(10):1916–1926. doi:10.1016/j.ophtha.2011.07.027.
  • Pohlmann D, Schlickeiser S, Metzner S, Lenglinger M, Winterhalter S, Pleyer U. Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs’ uveitis. PloS One. 2018;13(6):e0199301. doi:10.1371/journal.pone.0199301.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.